Form 4 for TPST Tempest Therapeutics, Inc.
Accepted 2026-03-25 00:00:00 ET · period of report 2026-03-24 · accession 0001931356-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-03-25 | 2026-03-24 | TPST | Angel Matthew | CEO, Pres, Dir, 10% | P - Purchase | $2.16 | +231.5K | 231.5K | New | +$500.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-24 | P | A | 231,482 | $2.16 | 231,482 | I By Factor Bioscience Inc. | — | — | (F1) The shares are held by Factor Bioscience Inc. ("Factor"). The Reporting Peron is the chief executive officer and chairman of the board of directors of Factor and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein. |